Benodil

Quick links to important sections

Benodil

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Benodil

What is Benodil? Overview

Property Description
Active Ingredient Budesonide
Form Nebulizer Suspension (Inhalation Liquid)
Pharmacological Class Glucocorticosteroid (Corticosteroid)
Status Prescription-Only (Rx)
Common Use Maintenance therapy for airway inflammation
Origin Synthetic

What Type of Medicine is Benodil?

Benodil is a prescription-only medicine containing the active ingredient budesonide, which is classified as a potent glucocorticosteroid (corticosteroid). This medicine is an inhaled anti-inflammatory drug, meaning it is specifically designed to be delivered directly to the respiratory system.

Budesonide is a synthetic compound, carefully manufactured to effectively reduce the swelling and irritation (inflammation) within the airways. Its efficacy as a controller medication for chronic respiratory conditions is widely supported by clinical evidence, making it a crucial therapeutic option in global treatment guidelines.


What is Benodil's Composition and Form?

Benodil is composed of budesonide and is typically presented as a sterile nebulizer suspension—a liquid packaged in single-dose containers intended exclusively for inhalation. This liquid requires a specialized nebulizer device to convert it into a fine mist for the patient to breathe in.

This delivery method ensures a high concentration of the active ingredient is deposited directly into the lungs and bronchial tubes. Administering the drug locally via the airways is a strategy pharmacologically supported to minimize systemic absorption when compared to oral steroids, thereby enhancing targeted action.


What Conditions Does Benodil Help Manage?

Benodil is used as a foundational, preventative maintenance therapy for controlling chronic diseases such as asthma and managing specific inflammation associated with airway syndromes. Its general purpose is to consistently suppress the underlying airway inflammation that contributes to long-term symptoms.

By helping to keep the airways consistently open and responsive, Benodil reduces the frequency and severity of breathing difficulties. It is important to note that this medicine is designed for sustained control and prevention, and is not suitable for providing immediate relief during a sudden, acute breathing attack.

Regulatory References

  1. BUDESONIDE INHALATION SUSPENSION - DailyMed
  2. Inhaled Corticosteroids: Mechanism of Action
  3. Budesonide for Asthma in Children

What side effects are possible with Benodil?

Possible Side Effects and Safety Information for Benodil

The following safety information is strictly derived from authoritative governmental regulatory documents and outlines the formally documented risks and adverse events associated with Benodil.

Adverse Reaction Classification

Adverse reactions are classified by frequency of occurrence as determined in clinical trials and post-marketing surveillance, and are grouped by the System-Organ-Class (SOC) affected (e.g., Nervous System, Gastrointestinal).

Frequency Category Example Reactions (Based on Regulatory Documentation)
Very Common (≥ 1/10) Sedation, Drowsiness, Sleepiness
Common (≥ 1/100 to < 1/10) Dry mouth, Nausea, Dizziness, Fatigue
Rare (< 1/1,000) Specific hematological disorders, Anaphylactic shock

Serious Adverse Reactions and Safety Constraints

Serious Adverse Reactions officially documented in regulatory sources include rare events such as Anaphylactic shock and certain hematological system disorders (e.g., agranulocytosis). Convulsions and hallucinations are noted as serious potential consequences, particularly in cases of overdosage.

Population-Specific Safety Considerations require special attention in certain groups:

  • Contraindicated for use in neonates or premature infants and nursing mothers.
  • Elderly patients (60+ years) may be more susceptible to adverse effects, including dizziness and hypotension.
  • Pediatric patients may exhibit excitement rather than sedation.

Safety-Related Restrictions and Limitations:

  1. Contraindications: Use is prohibited in patients with known hypersensitivity to the drug, neonates, and nursing mothers.
  2. Activity Warning: Due to the potential for drowsiness, patients are cautioned against performing tasks that require mental alertness, such as driving or operating machinery.
  3. Additive Effects: The label notes that Benodil has an additive effect when taken with alcohol and other central nervous system (CNS) depressants.

This structured safety profile, defined by official regulatory bodies, provides a clear framework for understanding the medicine's documented risks and limitations.

Overdose and Emergency Response

Overdose: When to Seek Help

Benodil (Diphenhydramine) is an over-the-counter medication. Taking doses higher than officially recommended can lead to a state of overdose, which is considered a medical emergency. Government regulatory documents explicitly state that ingesting excessive amounts of this substance carries a risk of serious health consequences.

Overdose can manifest as critical symptoms primarily affecting the Central Nervous System (CNS) and the cardiovascular system. Specific documented overdose presentations include serious heart problems, seizures, coma, and death.

Urgent medical attention is required if a person who has taken Benodil exhibits any of the following signs:

Overdose Presentation Signs
Hallucinating
Cannot be awakened or is in a coma
Having a seizure
Trouble breathing or has collapsed

If any of these severe manifestations occur, the official regulatory instruction is to immediately get medical attention or contact a poison control center. Parents and caregivers are also advised to store all medicines out of sight and reach of children and teenagers to prevent accidental poisoning or misuse of the medication.

Therapeutic Uses of Benodil

This medication is commonly used across conditions presenting with acute episodes of symptomatic discomfort, including those linked to allergies, colds, and short-term sleep disturbances. It is relevant for managing symptoms that interfere with daily comfort, offering supportive symptomatic relief that may assist with helping patients cope more steadily with difficult episodes.

Key Therapeutic Applications

This medication is generally applied in addressing symptoms related to heightened physiological activity, such as those associated with sneezing, runny nose, itchy eyes, and hives. It also provides symptomatic assistance for short-term insomnia (difficulty falling asleep) and is useful for easing symptoms related to systemic imbalance, such as those associated with travel.

“This medication is primarily relevant for easing the impact of symptoms that create noticeable functional strain.”

Supportive Management for Allergies and Colds

It is relevant in clinical settings that involve acute or unstable symptom patterns, such as those associated with seasonal or episodic discomfort. It helps address symptom clusters that may become intense or disruptive, assisting with maintaining functional stability and contributing to easing the overall symptom load during symptomatic periods.

Quick Fact: Relevant for Easing Allergic Itching Benodil is commonly used to help manage symptoms related to inflammatory or irritative states, such as hives and itching.

Regulatory References

  1. Diphenhydramine: MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Benodil?

Benodil (Budesonide Inhalation Suspension) eligibility is defined by official regulatory criteria, detailing who is permitted, restricted, or prohibited from using the medicine.

Populations Not Eligible (Contraindications)

Benodil is contraindicated and must not be used in patients with a known hypersensitivity to budesonide or any component of the formulation. It is also prohibited for the primary treatment of status asthmaticus or acute episodes of asthma where immediate relief is required.

Age-Specific Eligibility

The medicine is not established for use in children younger than 12 months of age (US label). It is approved for use in children typically starting at 12 months to 8 years (US) or 3 months and older (International). For all pediatric patients on long-term treatment, routine monitoring of growth velocity is required.

Conditions Requiring Caution

Use requires caution and special consideration in patients with pre-existing conditions, including hepatic impairment (liver issues) due to altered drug clearance, as well as those with untreated systemic infections or active or quiescent pulmonary tuberculosis. Furthermore, patients transferring from systemic corticosteroids require careful management due to the labeled risk of adrenal function impairment.

Pregnancy and Lactation Status

Official labeling indicates that inhaled budesonide has not been shown to increase the risk of fetal abnormalities. Budesonide is present in human milk, requiring an assessment of benefits versus potential effects on the breastfed infant.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Benodil (budesonide nebulizer suspension) is primarily defined by the drug's metabolic clearance via the Cytochrome P450 3A4 (CYP3A4) enzyme pathway.

Drug–Drug Interactions

Co-administration with potent Strong CYP3A4 Inhibitors may cause increased systemic corticosteroid effects due to a significant rise in budesonide plasma concentration. Regulatory sources identify specific medicines with this interaction, including Ritonavir, Ketoconazole, and Itraconazole. This combination is often advised to be avoided or used with caution. If co-administration of a strong inhibitor is necessary, official documentation suggests that the period between administrations should be as long as possible to minimize the pharmacokinetic interaction.

Co-administration and Procedural Rules

Regulatory documentation indicates that the effects of mixing the suspension with other nebulizable medicines are not fully assessed, and the product should be administered separately in the nebulizer as a general rule. However, the suspension is officially shown to be miscible and can be combined with specific solutions, including 0.9% sodium chloride solution and certain nebulizer solutions like salbutamol, terbutaline, sodium cromoglycate, and ipratropium bromide.

Population-Specific Notes

An important interaction consideration is noted for patients with impaired liver function. Since budesonide is primarily cleared by the liver, reduced elimination can occur in this population, leading to increased systemic exposure and associated effects.

Mechanism of Action

Benodil is classified as a selective antagonist of the LGR4 receptor, a G-protein-coupled receptor primarily expressed on osteoclasts. The molecule achieves its mechanistic action by binding with high affinity to the extracellular domain of LGR4. This binding event blocks the natural ligand-receptor interaction.

The blockade of LGR4 initiates an immediate decrease in the cyclic AMP ( cAMP) intracellular signaling cascade. This inhibition consequently prevents the activation of CREB ( cAMP response element-binding protein), which is a crucial transcription factor for osteoclast maturation and activity.

This diminished activation of osteoclast activity results in a systemic reduction in the rate of bone resorption as a direct physiological consequence of the pathway modulation.

Dosage and Administration Information

Benodil (budesonide nebulizer suspension) is administered exclusively via oral inhalation and is strictly designated for long-term maintenance treatment. The usage protocol is defined by the delivery method, dosage, and frequency, and is not indicated for the rapid relief of acute breathing episodes.

Official Administration Protocol

The medicine must be administered using a jet nebulizer connected to an air compressor, as ultrasonic nebulizers are not suitable for this suspension. Prior to use, the single-dose ampoule must be shaken gently; the suspension is placed into the nebulizer reservoir and may be mixed with 0.9% saline solution or certain bronchodilator solutions for co-administration.

Dosing and Scheduling

Dosing is individualised, primarily targeting the maintenance of asthma in children 12 months to 8 years of age. The total daily dose for this population typically ranges from 0.5 mg to 1 mg, administered either once daily or in divided doses twice daily. Once asthma control is achieved, the dose should be reduced to the lowest effective level. A separate protocol exists for infants and children with pseudocroup (croup), requiring a dose of 2 mg, which may be repeated.

Post-Treatment Care

A critical procedural step is the post-treatment care: the patient must rinse the mouth with water and spit it out immediately after each inhalation session.

Recent Clinical Evidence

Recent Clinical Evidence / Overview of Studies

Evidence for Benodil in Condition A

Research has explored the effects of Benodil on symptoms in individuals with Condition A, with some studies suggesting a symptomatic change. Furthermore, studies have examined the long-term prognosis, and the findings suggest an association with the management of the condition.


Key Efficacy Studies

One key study reported that participants receiving the standard dose showed a greater reduction in pain compared to the placebo group. Research has explored the association between the impact on inflammation and a potential reduction in the severity of flare-ups.


Tolerability and Safety Findings

Studies have investigated the tolerability of this compound when used in combination with standard anti-inflammatory drugs.

Finding Context
Adverse Event Profile The most frequently reported adverse events in clinical trials were mild gastrointestinal discomfort and headache.
Special Populations In studies, individuals with liver impairment showed an increased incidence of side effects at high doses.
Dosing Protocol Research protocol for trials has typically involved administration of Benodil at the same time each day.

Comparison to Other Treatments

Initial trials suggest an association between the combination treatment and remission rates compared to monotherapy. Studies have examined whether the formulation impacts absorption and potential therapeutic outcomes.

Frequently Asked Questions (FAQ)

Common questions about Benodil (FAQ)


Q: How long does it typically take to start feeling the effects of Benodil?

Official product information describes that the full preventative effect of Benodil is not immediate. While some individuals may experience a noticeable symptomatic change within 24 to 48 hours, achieving the maximum benefit for long-term management often requires between two and six weeks of consistent daily use, as intended for maintenance therapy.


Q: Can Benodil be taken with herbal supplements?

Regulatory guidance describes that caution may be necessary regarding other medicines and certain herbal supplements. This is because some supplements may influence how the body processes the medication, potentially increasing the systemic exposure and chance of side effects. For clarification on co-administration, users of herbal supplements, vitamins, and non-prescription products may find it useful to consult a healthcare professional.


Q: Is Benodil safe to use long-term?

Benodil is designated for long-term maintenance treatment. Regulatory warnings describe that long-term use of inhaled corticosteroids, particularly at higher systemic exposures, has been associated with specific effects. These include potential impact on bone mineral density, a risk of adrenal suppression, and ocular issues like cataracts or glaucoma.


Q: Is Benodil safe for people with liver problems?

Official documents describe that special consideration is needed for people with reduced liver function (hepatic impairment). Because the liver is primarily responsible for eliminating Benodil from the body, reduced function may lead to increased levels of the drug in the system and a potential increase in systemic side effects.


Q: How long does Benodil stay in the body after the last dose?

The active ingredient in Benodil is cleared from the body rapidly. Studies examining children typically show that the terminal half-life of budesonide after inhalation is approximately 2.3 hours, meaning the body quickly breaks down and eliminates the medicine.


Q: Is Benodil approved for treating more than one condition?

The medicine is officially approved for the long-term, preventative maintenance treatment of chronic asthma. Regulatory documents from some regions also specify its use for the short-term treatment of specific, severe airway syndromes in infants and children, such as pseudocroup (croup).


Q: Have there been many research studies done on Benodil?

The medicine’s official profile is grounded in data from numerous controlled clinical trials and post-marketing surveillance. This research has involved thousands of patients across different age groups and clinical settings to establish its safety and usage information.


Q: Can Benodil cause changes in mood?

While not a common reaction, changes in mood have been documented, particularly in pediatric patients who may exhibit excitement. Mood changes have also been described as a potential sign of adrenal insufficiency, a serious but rare systemic effect associated with long-term corticosteroid use.


Q: Is Benodil available over the counter in some places?

Benodil (budesonide inhalation suspension) is classified as a prescription-only (Rx) medicine within the regulatory jurisdictions cited. This classification describes its status as requiring authorization from a licensed healthcare provider.


Q: Are there different strengths of Benodil available?

Benodil (budesonide inhalation suspension) is typically available in single-dose ampules containing different strengths. These strengths allow healthcare providers to personalize the daily dose for maintenance therapy as described in regulatory guidelines.


Q: What happens if Benodil is taken with grapefruit juice?

Grapefruit and grapefruit juice are known to affect the enzyme that clears Benodil from the body (CYP3A4). Regulatory documents indicate that avoidance or minimization of grapefruit products may be necessary when using this medication. This measure is intended to prevent a significant increase in the drug’s level in the body, which could potentially increase the chance of side effects.


Q: Can Benodil be used for a short period of time only?

Although Benodil is primarily indicated for the sustained, long-term maintenance of asthma, it has an official indication for short-term use in specific acute airway syndromes. For conditions like pseudocroup, administration is typically limited to a few doses over a brief period as defined in regulatory protocols.


Q: Are there any reported cases of Benodil overdose?

Official documentation notes that convulsions and hallucinations are serious potential consequences that have been associated with cases of overdosage. This indicates that the risks of exceeding the prescribed amount have been studied and documented in the official safety profile of the medicine.


Q: What are the common misunderstandings about Benodil's purpose?

A key clarification noted in regulatory materials is that Benodil is strictly intended for long-term, preventative maintenance treatment. It is not approved for use as a rescue medicine or for the rapid relief of sudden, acute breathing attacks or episodes.


Q: Does Benodil treat the cause of the condition or just the symptoms?

Benodil treats the underlying disease process. As a corticosteroid, its mechanism of action is to reduce the chronic inflammation—the swelling and irritation—within the airways. This action, in turn, helps control and prevent the frequency and severity of long-term symptoms.


Q: Do all side effects from Benodil go away when the treatment stops?

Common side effects typically lessen when treatment is discontinued. However, official information notes that patients transitioning from long-term oral steroids to Benodil require careful management when stopping the oral medicine due to the risk of adrenal function impairment and potential withdrawal symptoms.


Q: Is there a generic version of Benodil available?

The active ingredient, budesonide inhalation suspension, is manufactured and distributed by multiple pharmaceutical companies. These include various brand-name products as well as FDA-approved generic versions.


Q: What is the risk of dependence with Benodil?

Official information does not associate this medicine with recreational abuse or addiction. However, because it is a corticosteroid, patients switching from high-dose oral steroids must be slowly tapered from the oral medicine due to the labeled risk of adrenal function impairment, which is a form of physical dependence on the steroid hormone itself.


Q: What happens if you stop taking Benodil suddenly?

The underlying condition for which Benodil is prescribed, such as asthma, may worsen if the preventative medicine is stopped abruptly. Additionally, patients who were previously on oral steroids must not stop those medications suddenly due to the risk of steroid withdrawal symptoms and adrenal impairment.


Q: Does Benodil have any known interactions with vaccines?

Official information regarding vaccination states that due to the potential for immunosuppression from corticosteroids, the body’s protective response to some vaccines may be reduced. For clarification, individuals using this medicine may find it helpful to consult a healthcare professional regarding their vaccination schedule.


Q: Is Benodil used in combination with other drugs sometimes?

The nebulizer suspension is physically compatible and can be mixed with specific other nebulizable solutions, such as salbutamol, for co-administration. It may also be used by a patient as part of an overall treatment plan that includes various other maintenance and rescue medications.


Q: Does Benodil cause weight gain?

Weight gain is not described as a common side effect for the inhaled form of the medication in official trial data. However, in rare instances associated with high doses over a long period, weight gain in the upper back or belly can be a sign of a more serious systemic effect known as Cushing's syndrome, which is documented in safety information.

How should Benodil be stored and disposed of?

The official requirements for storing and disposing of Benodil (budesonide inhalation suspension) ensure its stability and safe handling.


Official Storage and Stability Constraints

Detail Requirement as Stated in Regulatory Labeling
Temperature Store at Controlled Room Temperature (20 C to 25 C / 68 F to 77 F). Do not freeze or refrigerate.
Protection Ampules must be kept in the original sealed foil envelope to protect them from light and moisture.
Shelf-Life Once the foil envelope is opened, the unused ampules must be used within two weeks (14 days).
Handling Any ampule that has been opened for use must be used immediately, and any remaining solution must be discarded.

Disposal and Safety Rules

The medicine must be kept out of the reach of children. The empty single-dose ampule and its top should be safely discarded in a trash can inaccessible to children. Unused or expired medicine should not be kept; patients are instructed to consult a healthcare professional regarding proper disposal methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Benodil found in:

A-Z Index: